Skip to main content
Log in

Is circulating endothelin evaluation useful for clinicians?

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Porter L (2006) Blue Trane. La vita e la musica di John Coltrane Minimum Fax (eds.), EAN: 9788875211158, p 575

  2. Dhaun N, Webb DJ (2019) Endothelins in cardiovascular biology and therapeutics. Nat Rev Cardiol. https://doi.org/10.1038/s41569-019-0176-3

    Article  PubMed  Google Scholar 

  3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332(6163):411–415.

    Article  CAS  PubMed  Google Scholar 

  4. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ; Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I. Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005; 23(1):7–17

    Article  CAS  PubMed  Google Scholar 

  5. Ferri C, Properzi G, Tomassoni G, Santucci A, Desideri G, Giuliani AE, Starling RC, Ratliff NB, Cook DJ, McCarthy P, Young JB, Yamani MH (2002) Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation 105(15):1768–1771

    Article  CAS  PubMed  Google Scholar 

  6. Moroni C, Tolone S, Bondanini F, Schillaci O, Affricano C, Cassone R, Gaspardone A, Gaudio C (2019) Endothelin-1 in hypertensive patients with ischemic heart disease. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02095-3

    Article  Google Scholar 

  7. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N Engl J Med 338:784–790

    Article  CAS  PubMed  Google Scholar 

  8. Nakov R, Pfarr E, Eberle S (2002) Darusentan: an effective endothelin A receptor antagonist for treatment of hypertension. Am J Hypertens 15:583–589

    Article  CAS  PubMed  Google Scholar 

  9. Webb DJ (2010) DORADO: opportunity postponed: lessons from studies of endothelin receptor antagonists in treatment-resistant hypertension. Hypertension 56:806–807

    Article  CAS  PubMed  Google Scholar 

  10. Bakris GL (2010) Divergent results using clinic and ambulatory blood pressures: report of a darusentan resistant hypertension trial. Hypertension 56:824–830

    Article  CAS  PubMed  Google Scholar 

  11. Idorsia. Drug discovery & clinical development (2019) idorsia https://www.idorsia.com/documents/com/fact-sheets-presentations/fs-clinical-development.pdf

  12. US National Library of Medicine (2019) ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02603809

  13. Segers VF, Gevaert AB, Boen JR, Van Craenenbroeck EM, De Keulenaer GW (2019) Epigenetic regulation of intercellular communication in the heart. Am J Physiol Heart Circ Physiol. https://doi.org/10.1152/ajpheart.00038.2019

    Article  CAS  Google Scholar 

  14. Yu L, Yang G, Weng X, Liang P, Li L, Li J, Fan Z, Tian W, Wu X, Xu H, Fang M, Ji Y, Li Y, Chen Q, Xu Y (2015) Histone methyltransferase SET1 mediates angiotensin II–induced endothelin-1 transcription and cardiac hypertrophy in mice. Arterioscler Thromb Vasc Biol 35:1207–1217

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudio Ferri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statements on human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferri, C., Desideri, G. Is circulating endothelin evaluation useful for clinicians?. Intern Emerg Med 14, 1029–1031 (2019). https://doi.org/10.1007/s11739-019-02099-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-019-02099-z

Navigation